Clinical Edge Journal Scan

Breast cancer: Dose to left anterior descending artery tied to adverse cardiac events


 

Key clinical point: Patients with left-sided breast cancer (BC) who received radiation doses to the left anterior descending artery (LAD) experienced an elevated risk for adverse cardiac outcomes.

Major finding: Mean dose to LAD was associated with an increased risk for any cardiac event (hazard ratio [HR] 1.09; P = .006) and major cardiac events (HR 1.08; P = .022). Receiver operating characteristics analysis identified 2.8 Gy (area under the curve 0.69) as the mean LAD dose threshold, above which the risk for any cardiac event was higher ( P = .001).

Study details: Findings are from a retrospective study of 375 consecutively treated female patients with nonmetastatic, left-sided BC who received breast-conserving surgery/mastectomy and adjuvant radiation therapy.

Disclosures: This study did not receive any funding. The authors declared no conflict of interests.

Source: Zureick AH et al. Dose to the left anterior descending artery correlates with cardiac events following irradiation for breast cancer. Int J Radiat Oncol Biol Phys. 2022 (Apr 24). Doi: 10.1016/j.ijrobp.2022.04.019

Recommended Reading

Quadruple-negative breast cancer associated with poorest outcomes
MDedge Hematology and Oncology
ER+/HER2− BC: ET+bevacizumab switch is an efficacious and safer alternative to paclitaxel
MDedge Hematology and Oncology
Invasive BC: Digital breast tomosynthesis+s2D mammography superior to digital mammography
MDedge Hematology and Oncology
HER2+/HR− BC: Responders to deescalated trastuzumab+pertuzumab can safely omit paclitaxel
MDedge Hematology and Oncology
HR+/HER2− metastatic BC: No survival benefit with palbociclib+ET over capecitabine in patients who progress on AI therapy
MDedge Hematology and Oncology
ER+ breast cancer: Ibandronate fails to improve DFS in TEAM-IIB trial
MDedge Hematology and Oncology
Risk for bilateral breast cancer among women with a history of LCIS
MDedge Hematology and Oncology
Young women with postpartum breast cancer have worst survival
MDedge Hematology and Oncology
Prognostic factors in male breast cancer with bone metastases
MDedge Hematology and Oncology
Young age has no prognostic significance in HER2+ early BC
MDedge Hematology and Oncology